טוען...
Bisphosphonates in multiple myeloma: an updated network meta‐analysis
BACKGROUND: Bisphosphonates are specific inhibitors of osteoclastic activity and are used in the treatment of patients with multiple myeloma (MM). While bisphosphonates are shown to be effective in reducing vertebral fractures and pain, their role in improving overall survival (OS) remains unclear....
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2017
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486151/ https://ncbi.nlm.nih.gov/pubmed/29253322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003188.pub4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|